#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thromboangiitis obliterans Chondrodystrophy Anti-HLA antibody test positive Henoch-Schonlein purpura nephritis Cognitive disorder CDKL5 deficiency disorder Retinal artery occlusion Phaeochromocytoma Erythema Familial haemophagocytic lymphohistiocytosis Craniocerebral injury Small cell lung cancer recurrent Hyperoxaluria PIK3CA-activated mutation Haemophilia More trials…

    Learn about Rare Diseases

    Pleomorphic leiomyosarcoma – Treatment Prader-Willi syndrome – Basic Information Ornithine transcarbamoylase deficiency – Trials in Disease Lennox-Gastaut syndrome – Diagnostics Synovial sarcoma metastatic – Treatment Idiopathic pulmonary fibrosis – Life with Disease Leiomyosarcoma metastatic – Diagnostics Advanced systemic mastocytosis – Diagnostics Encephalitis autoimmune – Basic Information Crigler-Najjar syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    MZE829 Bay 3018250 Bms-986340 Lutikizumab Tumor Necrosis Factor-Alpha Macrogol 3350 Ly3454738 Thiopental Sodium Tomligisiran Dnth103 Quemliclustat RP2 Indometacin Gsk3915393 Idarubicin TAGRAXOFUSP Mycophenolate Mofetil Melphalan Hydrochloride Dronabinol Iron Sucrose More therapies…

    Learn about Your Condition

    Laryngeal cancer stage I Cardiogenic shock Exposure via breast milk Hypertension Sleep disorder Peripheral ischaemia Plasma cell myeloma recurrent COVID-19 Tissue anoxia Melanoma recurrent Essential hypertension Tuberculosis Metastases to peritoneum Breast cancer in situ Multiple sclerosis relapse More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Chronic Kidney Disease and Polycystic Kidney Disease Using Pyruvic Acid and MRI for Patients with These Conditions

    Recruiting

    2 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    • Chronic kidney disease
    Investigated Drugs:
    • Pyruvic Acid
    Denmark

  • Study on Managing Rheumatological Side Effects in Cancer Patients Using Fludeoxyglucose (18F) and Checkpoint Inhibitors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Fludeoxyglucose (18F)
    • Relatlimab
    • Ipilimumab
    The Netherlands

  • Study Comparing Progesterone and Ganirelix for Preventing LH Surge in Women Undergoing Ovarian Stimulation for Egg Donation

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Follitropin Alfa
    • Follitropin Alfa (Genetical Recombination)
    • Ganirelix
    Spain

  • Study comparing intranasal COVID-19 vaccine (LVT-001) with mRNA vaccine (bretovameran) as booster doses in healthy adults

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • LVT-001
    France

  • Study on Pain Relief Using Lidocaine and Sodium Chloride in Patients with Chronic Inflammatory Bowel Disease and Abdominal Pain

    Recruiting

    2 1 1
    Investigated Diseases:
    • Inflammatory bowel disease
    Investigated Drugs:
    • Sodium Chloride
    • Lidocaine Hydrochloride Monohydrate
    Belgium

  • Study on Using Ultrasound with Perflubutane and Laxative for Detecting Crohn’s Disease in Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Perflubutane
    • Macrogol 3350
    • Sodium Hydrogen Carbonate
    Norway
Previous Page
1 … 196 197 198 199 200 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!